Although p‐tau181 has been widely used as AD biomarker,1, 62 recent studies identified other epitopes, such as p‐tau21763 and p‐tau231,64 which have demonstrated greater sensitivity in detecting tau pathology. The gene discussed is MAPT; the disease is Alzheimer disease.